PGY-2 Residency in Hematology/Oncology Pharmacy Practice
Stanford Health Care (SHC) is world-renowned for advanced patient care, particularly for the treatment of cancer. It is recognized by U.S. News & World Report as one of "America's Best Hospitals" and currently ranked #129 in the U.S on the Best Hospital Honor Roll, and we are also a National Cancer Institute (NCI) Designated Cancer Center. Stanford Health Care has a close relationship with both the Stanford University School of Medicine and Lucile Packard Children's Hospital, an adjacent pediatric teaching hospital providing general acute and tertiary care. The hospitals are located on three different sites, the Stanford University campus in Palo Alto, California; it is about 20 miles north of San Jose and about 40 miles south of San Francisco, Redwood City, and San Jose (South Bay).
Clinical pharmacists at Stanford Health Care cover all acute patient care areas and select ambulatory care clinics.
PGY-2 Hematology/Oncology Program Director: Eun Jeong Kim, Pharm.D., MS, BCOP, BCPS
Stanford Health Care Department of Pharmacy 300 Pasteur Drive, Room H0301 Stanford, CA 94305-5616
The Hematology/Oncology Residency at Stanford Health Care is a PGY-2 specialty training program that offers extensive hematology and oncology experiences at Stanford Comprehensive Cancer Center. Two applicants are accepted per year.
The program is designed to transition PGY-1 residency graduates from general practice to specialized practice focused on the care of patients with oncologic and/or hematologic disorders. Residency graduates will be equipped to participate as integral members of interdisciplinary teams, assuming responsibility for pharmaceutical care.
Throughout the program, the resident will gain practical experience in the management in neoplastic diseases as well as cancer-related and cancer treatment-related disorders. Due to the prominent use of investigational drugs in the treatment of cancer, the resident will also gain the knowledge and skills necessary to practice effectively in clinical research environments. They will be able to manage the preparation, distribution, and disposal of hazardous medications in both inpatient and ambulatory settings. Their experience will also include leadership in formulary decision-making for cancer-related medications. Groomed for practice leadership, the PGY-2 Hematology/Oncology resident will be able to successfully serve health-care organizations with the clinical and practice skills necessary for effective decision-making in the treatment of oncologic and hematologic disorders.
The goal of the PGY-2 Hematology/Oncology Residency Program is to provide a broad experience-based foundation in hematology/oncology, to develop his/her clinical skills, and to prepare for a comprehensive clinical practice in hematology/oncology.
The Hematology/Oncology Specialty Residency is accredited by the American Society of Health System Pharmacists (ASHP). The program follows the ASHP Residency Learning System (RLS) and its goals and learning objectives are consistent with standards developed by ASHP.
Required Program Activities
Orientation/Training – 1-2 weeks
Inpatient Oncology – 4-6 weeks
Inpatient Hematology – 4-6 weeks
Inpatient Blood and Marrow Transplantation (BMT) – 4-5 weeks
Outpatient Hematology/Oncology/BMT Clinics – 12 weeks and longitudinal
Research Project – longitudinal
Chemotherapy Preparation and Dispensing – longitudinal
* A maximum of one off-site rotation will be permitted.
Specialized Residency Requirement
Complete and present a research project at the Western States Conference and/or HOPA annual meeting.
Participate in teaching activities with PGY-1 residents and pharmacy students
Prepare and present drug monograph for the Pharmacy & Therapeutics Committee
Staff minimum 8-16 hours every 4 weeks
Attend hematology/oncology related committee meetings and teaching sessions
Participation in our Hematology/Oncology Specialty Residency Program requires a Pharm.D. degree from an ACPE-accredited College or School of Pharmacy and completion of an ASHP-accredited PGY-1 residency. Out of state candidates must obtain a California Intern license prior to the first day of residency and California Pharmacist licensure must be obtained within 3 months of start date of residency
About Stanford Health Care
The Department of Pharmacy provides integrated, cost-effective pharmaceutical services to Stanford Health Care (SHC). These patient-focused services include medication delivery, therapeutic recommendations, and promotion of optimal drug therapy.
To advance its mission, the department provides a supportive environment for professional training and development. The Department of Pharmacy participates in the American Society of Health-System Pharmacists (ASHP) Residency program. Three ASHP-accredited residency training programs are offered including a PGY-1 pharmacy practice residency and two specialty PGY-2 residencies in Critical Care and Oncology/Hematology. Three additional PGY-2 programs are applying for pre-candidate status through ASHP to include Infectious Disease, Emergency Medicine, and Health Services Administration and Leadership. Stanford pharmacists also precept pharmacy students on clerkship rotations